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Abstract: Acute oesophageal necrosis (AON) is a rare condition characterised by the endoscopic
finding of diffuse, circumferential, black mucosal pigmentation of the oesophagus, which typically
stops at the gastro-oesophageal junction. This observational study aimed to assess the occurrence,
clinical characteristics and outcomes of AON in a consecutive endoscopic cohort in a single tertiary
university centre. A retrospective analysis of endoscopic data of upper gastrointestinal endoscopy
(UGE) was carried out from 2008 to 2018. Out of 25,970 UGE, 16 patients (0.06%) had AON; 75.0%
were men with a median age of 75 years. Almost all patients underwent diagnosis during emergency
UGE performed for gastrointestinal bleeding, but one patient was diagnosed during elective UGE
for persistent vomiting and diarrhoea. All patients reported one or more pre-existing comorbidities
and concomitant acute events. Two patients had AON as the first presentation of Zollinger–Ellison
syndrome (ZES). One patient developed an oesophageal stenosis, and another patient presented
a relapse of AON. Mortality was 50%, but no patient died as a direct consequence of AON. AON
is a rare cause of gastrointestinal bleeding diagnosed mainly during emergency UGE. Our study
showed that ZES might manifest with this critical presentation, and endoscopists must be aware of
this evidence.
Keywords: black oesophagus; acute oesophageal necrosis; gastrointestinal bleeding; upper gastrointestinal
endoscopy; oesophageal stenosis; Zollinger–Ellison syndrome
1. Introduction
Acute oesophageal necrosis (AON), so-called black oesophagus, is a rare condition characterised by
the endoscopic finding of diffuse, often circumferential, black mucosal pigmentation of the oesophagus,
which typically stops at the gastro-oesophageal junction [1].
Epidemiological data of AON are scant, and the prevalence of this condition is supposed to be
low. In fact, large retrospective series reported that the estimated incidence ranged from 0.01% [2,3]
to 0.28% [4].
AON is more frequent in elderly men with medical comorbidities, often presenting with upper
gastrointestinal bleeding, ranging from haematemesis, coffee ground emesis, and melena [1,5,6].
Prognosis is poor, with an overall mortality of 32% usually related to the underlying comorbidities and
an estimated specific mortality of 6% [1,5,6].
The AON aetiology is likely multifactorial. It has been hypothesized that AON arises from
a combination of oesophageal hypoperfusion with consequent ischaemia, impaired mucosal defence
barrier and injury related to reflux of gastric contents [2]. To date, there has been no specific therapeutic
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protocol for this condition, and medical management has been directed to treat the coexisting
underlying illness.
The aim of this observational retrospective study was to assess the occurrence, clinical characteristics and
outcomes of AON in a consecutive endoscopic cohort over an 11-year period in a tertiary university centre.
2. Materials and Methods
A retrospective analysis of endoscopic data of elective and emergency upper gastrointestinal
endoscopy (UGE) was carried out from January 2008 to December 2018 in a single tertiary university
centre. Our electronic endoscopic database (Endobase Olympus) was searched using the following
keywords: “oesophagus”, “black”, “necrosis”, and “necrotic”.
The criterion for the diagnosis of AON was the presence of circumferential black appearance of
oesophageal mucosa that stops abruptly at the gastro-oesophageal junction [1–4,7]. Patients with other
causes of oesophageal injury, such as caustic ingestion, severe esophagitis, malignancies and other
benign disorders, were excluded. Gastric and duodenal endoscopic findings were assessed in all AON
cases. Duodenal involvement-associated AON was considered in the presence of erosions, ulcers or
necrotic aspects of the mucosa of the bulb and of the second portion.
Clinical records, including demographic, laboratory findings, radiological exams, pharmacological
history, medical treatment, and outcome, were collected; each patient comorbidity was reported and
expressed using the Charlson Index [8]. Anaemia was considered severe, moderate or mild when
haemoglobin levels were ≤ 12–13, 8–10, and ≤ 8 g/dL, respectively [9].
Data were expressed as the percentage (%) of the total, or the median and interquartile range IQR
or a range. The study was approved by the local ethics committee.
3. Results
According to the electronic search, 88 (0.34%) patients out of 25,970 were found in our endoscopic
database. All endoscopic reports were individually checked to carefully ascertain the AON diagnostic
criteria. Of the 88 patients, 72 were excluded, and 16 patients were diagnosed with AON (Figure 1).
Almost all AON diagnoses were performed during emergency UGE [15/2515 (0.60%)], and only one
case of AON was found during an elective exam [1/23,455 (0.004%)].
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Figure 1. Flow-chart of the study. UGE, upper gastrointestinal endoscopy; AON, acute oesophageal necrosis.
3.1. Demographics, Clinical Presentation and Comorbidities
Of the 16 patients, 12 (75.0%) were men with a median age of 75 years (range 47–89).
The reasons for hospitalization were as follows: nine patients with upper gastrointestinal bleeding
(56.2%), two patients with abdominal pain (12.5%), one patient with fever, one with persistent vomiting
and diarrhoea, one with acute renal failure, one with traumatic fracture and one with dysphagia.
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The only case of AON observed during an elective endoscopy was admitted for persistent vomiting
and diarrhoea.
Clinical and laboratory data at the time of endoscopy, with indications for UGE, are reported
in Table 1.
Table 1. Clinical, laboratory data, and indications for UGE in AON patients (n = 16).
Physical Examination
Hypotension (lower than 100/60 mmHg) 3/16 (18.7%)
Tachycardia (>100 bpm) 3/16 (18.7%)
Hypoxemia (SpO2 < 60) 1/16 (6.2%)
Laboratory Analysis
Leukocytosis (WBC > 10.000/µL) 13/16 (81.2%)
Increased C-reactive protein (>0.5
mg/dL) 12 /16 (75%)
Anaemia 11/16 (68.7%)
Mild 6/11 (54.5%)
Moderate 2/11 (18.2%)
Severe 3/11 (27.3%)
Increased glycaemia (>100 mg/dL) 13/16 (81.2%)
Increased creatinine (>1.5 mg/dL) 12 /16 (75%)
Hypoalbuminemia (<3 g/dL) * 10/11 (90.9%)
Indications for UGE
Upper GI bleeding 13/16 (81.2%)
Vomiting 1/16 (6.2%)
Worsening of anaemia 1/16 (6.2%)
Dysphagia 1/16 (6.2%)
Bpm = beats per minute; UGE = upper gastrointestinal endoscopy; GI = gastrointestinal; WBC = White blood cell.
* Albumin dosage was available in 11 patients.
Haemodynamic instability (hypotension and tachycardia) was present in three patients, one of
which also presented hypoxemia. Physical examination of the other 13 AON patients was
unremarkable. Thirteen patients (81.2%) had leukocytosis [median white blood cell count 14.800/µL
(IQR = 13.000–18.700)], and 12 patients (75%) had elevated C-reactive protein [median 2.9 mg/dL
(IQR = 2–12.3)]. Eleven patients (68.7%) had anaemia, and twelve (75%) had an elevated creatinine
level [median 1.3 mg/dL (IQR = 1.9–5.4)], but a known history of chronic renal failure was reported
only in five patients. Thirteen patients (81.2%) showed hyperglycaemia levels [median 185 mg/dL
(IQR = 113–278)], but only seven of them were diabetic. Ten patients had low levels of albumin
[median 2.8 g/dL (IQR = 2.1–3.6)].
All patients reported one or more concomitant pre-existing comorbidities: seven patients (43.7%)
had diabetes, six (37.5%) had arterial hypertension, five (31.2%) had chronic renal failure, three (18.7%)
had chronic ischaemic heart disease, three (18.7%) cerebral vascular disease and two (12.5%) had
active malignancies (pancreatic adenocarcinoma). Concomitant acute events at the time of AON
diagnosis were reported in almost all patients: seven (43.7%) had pneumonia, six (37.5%) had acute
renal failure, two (12.5%) had Clostridium difficile colitis, one had acute myocardial infarction and one
developed AON a few days after orthopaedic surgery. Two patients had AON as the first presentation
of Zollinger–Ellison syndrome (ZES). Pre-existing and concomitant comorbidities in each patient are
fully reported in Table 2.
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Table 2. Demographic characteristics, comorbidities, endoscopic findings and outcome of patients with AON.
Year of
Diagnosis Age Gender Chronic Comorbidities
Acute
Concomitant
Comorbidities
Charlson
Index
Oesophageal
Necrosis
Extension
Duodenal
Involvement
Other
Endoscopic
Findings
Outcome
2008 74 M
Chronic renal failure, diabetes, chronic
ischaemic heart disease and cerebral
vascular disease
Acute renal
failure 5 I-II-III
Duodenal’s
ulcers -
Discharged without
follow-up endoscopy
2009 76 M Cerebral vascular disease Pneumonia andsepsis 3 I-II-III
Duodenal’s
ulcers - Death from septic shock
2010 80 M Chronic renal failure Pneumonia andacute renal failure 5 I-II-III
Bulb’s
necrosis
Necrotic
aspect of
pylorus
Death from multi-organ failure
2010 74 M Chronic renal failure, dilatativecardiomyopathy and COPD
Acute renal
failure 7 I-II-III - - Lost to follow-up
2012 47 M Diabetes, atrial fibrillation and psoriasis Pneumonia 3 II- III - Hiatal hernia Oesophageal stenosis
2012 69 M Arterial hypertension, diabetes anddepressive syndrome
Vertebral fracture
and CD colitis 3 III
Duodenal’s
ulcers
Hiatal hernia
Mallory Weiss
Discharged without
follow-up endoscopy
2014 81 M Chronic renal failure, silicosis andbrachy-tachycardia syndrome Pneumonia 6 I-II-III
Duodenal’s
ulcers - Death from multi-organ failure
2016 64 M IV stage pancreatic adenocarcinoma Recent NSAIDassumption 8 II-III Bulb’s ulcers Hiatal hernia Death from acute renal failure
2016 65 F Zollinger–Ellison syndromein metastatic NET
Vomiting and
diarrhoea 8 I-II-III *
Duodenal’s
ulcers Hiatal hernia Remission at follow-up UGE
2016 85 M Alzheimer disease, decubitus lesions andatrial fibrillation
Pneumonia and
CD colitis 5 III
Duodenal’s
erosions Death from septic shock
2016 84 F
Zollinger–Ellison syndrome in pancreatic
gastrinoma, chronic ischaemic heart
disease and arteria hypertension
Pneumonia 12 III Duodenal’sulcers Hiatal hernia
AON relapse 3 weeks after the
first episode
2017 87 F
Pancreatic adenocarcinoma, chronic
ischaemic heart disease, hypertension,
diabetes, Parkinson disease and
senile dementia
Acute renal
failure 9 III
Duodenal’s
erosions Hiatal hernia Death from acute renal failure
2018 71 M Diabetes Superficialthrombophlebitis 4 II- III - - Remission at follow-up UGE
2018 89 M Hypertension, diabetes, dyslipidaemiaand glaucoma Pneumonia 5 III -
Hiatal hernia
gastric
volvolus
Death from septic shock
2018 66 M Charcot Marie Tooth polyneuropathy,arterial hypertension and diabetes
Acute renal
failure 3 I-II-III
Duodenal’s
ulcers - Remission at follow-up UGE
2018 77 F
Cerebral vascular disease, Alzheimer
disease, arterial hypertension and chronic
renal failure
NSTEMI and
acute on chronic
renal failure
7 II-III Necrotic areasof II portion - Death from multi-organ failure
M, male; F, female; NET, neuroendocrine tumour; CD, Clostridium difficile; NSAID, nonsteroidal anti-inflammatory drug; COPD, chronic obstructive pulmonary disease; UGE, upper
gastrointestinal endoscopy; III, distal one-third; II, distal two-third; I, proximal one-third; * Elective endoscopy.
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3.2. Endoscopic Findings
AON was involved the entire length of oesophagus in seven patients (43.8%), the distal one-third
in five (31.2%) and the distal two-thirds in four (25%) patients. Concomitant duodenal abnormalities
were reported in 12 patients (75%): eight (50%) presented frank duodenal ulcers, two patients presented
duodenal erosions, and the other two patients presented a necrotic aspect of the duodenum. Further
endoscopic findings included seven cases of hiatal hernia, one case of Mallory–Weiss lesion, one case
of gastric volvulus and one patient presenting necrotic aspect of the pylorus.
Endoscopic gastric and duodenal findings with respect to oesophageal necrosis extension are
reported in Figure 2. Endoscopic presentation of a patient with AON is showed in Figure 3.
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3.3. Medical and Endoscopic Treatment
Medical treatment for AON included intravenous proton pump inhibitors in all patients (81.2%
continuous infusion for at least 72 h; 18.8% with twice a day intravenous administration). Nil per os
and total parenteral nutrition were prescribed in 60% of patients. The majority of patients received
antibiotics (73%) with associated antimycotics (25%). Eight patients (50%) required 1–4 red blood cell
transfusions during hospitalization and two somatostatin infusions.
Among the twelve patients with duodenal involvement, three patients required endoscopic
haemostasis due to ulcer bleeding. One patient further required transcatheter angiographic
embolization and surgery to treat bleeding from duodenal ulcers.
3.4. Outcome
None of the patients developed oesophageal perforation. Specifically, in only nine cases,
contrast-enhanced computed tomography CT was performed within 24 h of AON diagnosis, showing
oesophageal thickening in five patients and duodenal thickening in three patients.
Eight patients (50%) died between 1–30 days of an AON event: three (37.5%) died from multi-organ
failure, three (37.5%) died from septic shock, and two patients (25%) died from acute renal failure.
None of the patients who died from septic shock had CT signs of perforation.
At follow-up endoscopy, three patients showed AON remission, one patient developed
oesophageal stenosis as an AON complication, and one patient complaining of vomiting and diarrhoea
presented an AON relapse three weeks after the first episode (Figure 4). Notably, patients with AON
recurrence are diagnosed with ZES.
Two patients completed uneventful hospitalization and were discharged without follow-up
endoscopy. One patient was transferred to another hospital, and he was lost to follow-up.
The two patients with ZES underwent UGE twenty-eight months after the first AON episode,
without showing any significant endoscopic findings.
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presentation of patient who presented AON recurrence. 1. AON, endoscopic presentation at first
episode; 2. AON remission after 15 days; 3. AON recurrence after 3 weeks.
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4. Discussion
This study assessed the occurrence of AON in a consecutive endoscopic cohort over an 11-year
period in a tertiary university centre. To the best of our knowledge, only a few case reports and case
series describing AON are available, and the prevalence of this condition is still unknown.
Our study showed that AON is a very rare condition with a prevalence of 0.06%. Retrospective
reports published more than twenty years ago reported an incidence that varies between 0.01% and
0.28% [2–4]; these data are quite similar compared to our report, further indicating the rare occurrence
of AON.
The current study showed some interesting data. First, in our AON cohort, two patients presented
a diagnosis of ZES. To our knowledge, this is the first time that AON has been reported as the first
presentation of ZES; this represented a very interesting association, suggesting the possibility that some
factors (i.e., acid hypersecretion) might contribute to the chemical and/or ischaemic injury of AON.
Erosive oesophagitis has been frequently reported in patients with ZES; in a study by Hirschowitz et al.,
erosive oesophagitis was reported in 70% of ZES patients, with more than half of those patients having
severe oesophagitis and 40% with complicated lesions (stricture, ulcer, or Barrett’s) [10]. On the other
hand, an old report by Moreto et al. cited a single case of AON diagnosed after a surgical intervention
of gastrinoma but unfortunately without reporting any additional patient data [3]. Although it is
possible to speculate that hyperacidity might play an important role in the development of AON
in these patients, it is possible that other specific triggers may act as concomitant mucosal injuries.
Second, we observed that one patient experienced an AON reoccurrence three weeks after the
first event. This patient was affected by chronic ischaemic heart disease, hypertension and pneumonia
and was subsequently diagnosed with ZES. AON reoccurrence is a rare event that has rarely been
observed [11,12]. To our knowledge, only two other cases with AON relapse have been reported.
Tanaka et al. reported the case of a male patient with multiple comorbidities (diabetes mellitus,
hypertension, hyperlipidaemia, and angina pectoris) with a reoccurrence after approximately 5 months
from the first episode [11], and Ramos et al. described a patient who developed a new AON after
4 months [12]. Even if recurrence is rare, it represents an important event to consider in this setting.
Third, we reported a patient with AON during an elective UGE performed for persistent vomiting
and diarrhoea. This is a quite unusual clinical presentation since the majority of patients received
a diagnosis of AON during an emergency UGE performed for gastrointestinal bleeding. However,
in a recent case series, the case of a patient who incidentally received a diagnosis of AON during
the endoscopic placement of a naso-gastrojejunal tube was reported [13], and in a previous report,
an asymptomatic AON patient diagnosed during a percutaneous gastrostomy tube placement was
described [5]. These atypical clinical presentations substantiated the hypothesis that AON might have
a subclinical presentation, likely due to the short duration of the ischaemic/chemical damage that
promoted spontaneous mucosal healing; on the other hand, it is possible that an early diagnosis has as
counterpart a vague clinical scenario.
According to previous reports, our data show that AON mainly affected elderly male patients.
We found that three-quarters of patients were male with a median age of 75 years, similar to other
reports where men are four times more commonly affected than women, with a peak of incidence in the
sixth or seventh decade of life [5,6]. In addition, we confirmed that AON patients have multiple chronic
and overlapping acute comorbidities, presenting in the majority of cases with upper gastrointestinal
bleeding. However, even if gastrointestinal bleeding (i.e., haematemesis and melena) is the indication
to perform UGE in more than 80% of AON patients, haemodynamic instability was observed only
in a few patients.
Regarding the endoscopic findings, we reported that AON involved the entire length of oesophagus
in almost half of AON patients, mostly with concomitant duodenal findings.
Even if AON more frequently affected the distal one-third and the distal two-thirds of the
oesophagus, Lamers et al. also reported panoesophageal involvement in a remarkable number of
AON patients (three out of five) [13]. Similar to what has been previously reported, the extent of
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oesophageal involvement seemed to be related to the duodenal disease, with almost all patients with
panoesophageal injury having a duodenal injury as ulcer and bulb necrosis. This phenomenon might
be likely explained by the common blood supply from the celiac axis branches to the oesophagus and
duodenum. The typical relative sparing of gastric mucosa might be explained by the different response
to the acid insult, since compared to gastric mucosa, oesophageal and duodenal mucosa presented
a slower healing process. In addition, duodenal lesions may result in gastric outlet obstruction that,
in turn, potentiates the development of mucosal necrosis of the distal oesophagus [1,14].
Oesophageal perforation is the most serious AON complication, generally occurring in less than
7% of patients [5,6]; however, in our AON cohort, no case of perforation has been reported. On the
other hand, we documented stenosis as a complication of AON in a patient with involvement of the
distal two-thirds of the oesophagus. We found a prevalence of approximately 6%, which is quite
similar to other cohorts in which the reported frequency of oesophageal stenosis has been reported
in 10% of patients [5,6].
Then, we found a mortality rate of 50% with no patients who died as a direct consequence of
AON. Even if no patient died from AON, the overall mortality seems slightly higher compared to
previous studies: Augusto et al. showed a mortality rate of 34.5%, and none was a direct consequence
of AON [4], whereas Gurvits et al. reported a 5.7% mortality rate due to AON and an overall mortality
rate of 31.8% [4,5]. In a more recent study, the mortality rate was 12.5% and unrelated to AON [14].
Even if the specific AON mortality rate remained low, these overall mortality proportions might reflect
the clinical severity of included patients in the specific cohort.
We are aware of some limitations of this study. The main limitation is the retrospective nature of
the data collection. In addition, oesophageal biopsies were not always available; however, the diagnosis
of AON is endoscopic, and oesophageal biopsies are supportive but not required to make the proper
diagnosis. This AON cohort has been collected in a single tertiary university centre, which might affect
the generalisability of the study’s results.
5. Conclusions
In conclusion, AON is a rare cause of gastrointestinal bleeding diagnosed mainly during emergency
UGE, but it can diagnosed during elective endoscopy. Beyond the well-known association between
AON and elderly patients with multiple comorbidities, our study showed that ZES might manifest
with this critical presentation, and endoscopists must be aware of this evidence.
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